In a study exploring the anti-inflammatory effects of topical Tetracycline (TET) on AD in a mouse model, TET was found to suppress the expression of inflammatory cytokines, including IL-1β, in skin lesions. The gene discussed is IL1B; the disease is Alzheimer disease.